Benzinga··Mohd HaiderEli Lilly's VERVE-102 Gene Therapy Cuts LDL Cholesterol 62%, Draws VC Praise
Eli Lilly reports VERVE-102 gene therapy reduced LDL cholesterol up to 62% in Phase 1b trials with no serious adverse events, earning FDA Fast Track designation.
LLYbiotechgene therapy